Treatments for MDS and Secondary AML Part 1, Low-Risk MDS @AAMDSIF

Treatments for MDS and Secondary AML Part 1, Low-Risk MDS @AAMDSIF

Uploaded April 2024 | Updated September 2026, 2 hours ago

From the 2024 International Bone Marrow Failure Disease Scientific Symposium:
Dr. Jacqueline Garcia and Dr. Andrew Brunner describe the presentations about Low-Risk MDS

#mds #bloodcancer #aml

Treatments for MDS and Secondary AML Part 1, Low-Risk MDS

2022 September Living with PNH: A Patient Panel Discussion

Acute Myeloid Leukemia: Highlights of the Presentation by Dr Uma Borate from ASH 2023 Symposium

Survivorship: Life after Diagnosis - 2023 Omaha Patient and Family Hybrid Conference

Transplant for Older Patients with MDS

Vexas Syndrome

8th Seattle Patient Conference - MDS Non Transplant Therapies

AAMDSIF 40th Anniversary Summit: Dr. Joachim Deeg Receives Lifetime Achievement Award

Aplastic Anemia Non-Transplant Therapies and Clinical Trials - 2023 Patient-Family Conference NE

Clonal Hematopoiesis - Presentation Highlights from ASH 2023 with Abhay Singh, MD, MPH

2022 Living with Aplastic Anemia: A Patient Panel

Living with PNH: Talking with Your Doctor

Treatments for MDS and Secondary AML Part 1, Low-Risk MDS